KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Nutanix (NTNX) Research & Development (2016 - 2026)

Nutanix (NTNX) has 12 years of Research & Development data on record, last reported at $202.3 million in Q1 2026.

  • On a quarterly basis, Research & Development rose 10.65% to $202.3 million in Q1 2026 year-over-year; TTM through Jan 2026 was $769.8 million, a 12.65% increase, with the full-year FY2025 number at $736.8 million, up 15.31% from a year prior.
  • Research & Development reached $202.3 million in Q1 2026 per NTNX's latest filing, up from $187.5 million in the prior quarter.
  • Over the last five years, Research & Development for NTNX hit a ceiling of $202.3 million in Q1 2026 and a floor of $141.9 million in Q1 2022.
  • A 5-year average of $163.2 million and a median of $159.2 million in 2024 define the central range for Research & Development.
  • Peak YoY movement for Research & Development: dropped 1.78% in 2022, then grew 17.08% in 2025.
  • Tracing NTNX's Research & Development over 5 years: stood at $149.4 million in 2022, then increased by 1.69% to $152.0 million in 2023, then increased by 14.47% to $174.0 million in 2024, then grew by 7.77% to $187.5 million in 2025, then rose by 7.88% to $202.3 million in 2026.
  • Business Quant data shows Research & Development for NTNX at $202.3 million in Q1 2026, $187.5 million in Q4 2025, and $193.7 million in Q3 2025.